A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants

NCT01688635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY2963016
DRUG: US Approved Lantus

Sponsor

Eli Lilly and Company